TABLE 2.
Expression of surface inflammatory receptors on monocytes after stimulation of whole blood with PepG or LTA
| Treatment | Mean specific fluorescence intensity (± SEM)a
|
||||
|---|---|---|---|---|---|
| CD14 | ICAM-1 | LFA-3 | FcγRI | HLA-DR | |
| Untreated | 60.5 ± 12.2 | 27.3 ± 4.5 | 17.5 ± 1.1 | 18.4 ± 1.3 | 62.0 ± 11.7 |
| PepG (S. aureus) | 114.6 ± 20.2b | 59.3 ±13.3b | 15.8 ± 0.6 | 19.5 ± 1.7 | 105.7 ± 15.6b |
| PepG (B. subtilis) | 115.2 ± 21.3b | 69.7 ± 17.4b | 15.8 ± 1.0 | 18.8 ± 1.7 | 106.8 ± 16.3b |
| LTA | 103.2 ± 14.1b | 67.2 ± 16.7b | 16.2 ± 1.1 | 17.0 ± 1.8 | 127.3 ± 26.6b |
a
Values are for specific fluorescence intensity after appropriate gating for monocytes in whole blood treated with PepG (10 μg/ml) or LTA (100 μg/ml).
b
Significantly different (P < 0.05) from the value for the untreated control group as calculated by analysis of variance with Tukey post hoc assessment.